Value of B-type natriuretic peptide for identifying significantly elevated pulmonary artery wedge pressure in patients treated for established chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

American Journal of Cardiology

Volumn 95, Issue 7, 2005, Pages 883-885

  Parsonage, William A ^a   Galbraith, Andrew J ^b   Koerbin, Gary L ^b   Potter, Julia M ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMMERCIAL PHENOMENA; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY DIAGNOSIS; LONG TERM CARE; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SENSITIVITY ANALYSIS;

EID: 15244352717     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.12.021     Document Type: Article

References (13)

1. M. Packer, P.A. Poole-Wilson, P.W. Armstrong, J.G. Cleland, J.D. Horowitz, B.M. Massie, L. Ryden, K. Thygesen, B.F. Uretsky Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure ATLAS Study Group Circulation 100 1999 2312 2318
2. L.W. Stevenson, J.H. Tillisch, M. Hamilton, M. Luu, C. Chelimsky-Fallick, J. Moriguchi, J. Kobashigawa, J. Walden Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy Am J Cardiol 66 1990 1348 1354
3. A.M. Richards, J.G. Lainchbury, M.G. Nicholls, R.W. Troughton, T.G. Yandle BNP in hormone-guided treatment of heart failure Trends Endocrinol Metab 13 2002 151 155
4. K. Maeda, T. Tsutamoto, A. Wada, T. Hisanaga, M. Kinoshita Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 135 1998 825 832
5. A.M. Richards, I.G. Crozier, T.G. Yandle, E.A. Espiner, H. Ikram, M.G. Nicholls Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease Br Heart J 69 1993 414 417
6. A.E. Raine, P. Erne, E. Burgisser, F.B. Muller, P. Bolli, F. Burkart, F.R. Buhler Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure N Engl J Med 315 1986 533 537
7. J.L. Rouleau, C. Kortas, D. Bichet, J. de Champlain Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms Am Heart J 116 1988 746 757
8. C. Haug, A. Metzele, M. Kochs, V. Hombach, A. Grunert Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure Clin Cardiol 16 1993 553 557
9. M. Nakamura, N. Arakawa, Y. Abe, H. Yoshida, S. Miura, M. Kato, H. Ikram Relationship between plasma atrial natriuretic peptide concentration and atrial pressure in acute and chronic heart failure Jpn Heart J 31 1990 425 434
10. W.H.W. Tang, J.P. Girod, M.J. Lee, R.C. Starling, J.B. Young, F. Van Lente, G.S. Francis Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure Circulation 108 2003 2964 2966
11. T.A. McDonagh, S.D. Robb, D.R. Murdoch, J.J. Morton, I. Ford, C.E. Morrison, H. Tunstall-Pedoe, J.J. McMurray, H.J. Dargie Biochemical detection of left-ventricular systolic dysfunction Lancet 351 1998 9 13
12. A.S. Maisel, P. Krishnaswamy, R.M. Nowak, J. McCord, J.E. Hollander, P. Duc, T. Omland, A.B. Storrow, W.T. Abraham, A.H. Wu Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
13. R. Pfister, M. Scholz, K. Wielckens, E. Erdmann, C.A. Schneider Use of NT-proBNP in routine testing and comparison to BNP Eur J Heart Failure 6 2004 289 293